Kwality Pharmaceuticals Limited announced audited standalone and consolidated earnings results for the second half and full year ended March 31, 2017. For the second half, on standalone basis, the company reported net sales of INR 504.281 million compared with INR 397.178 million for the same period a year ago. Profit from operation before other income, finance cost and exceptional items was INR 38.906 million compared with INR 20.006 million for the same period a year ago. Profit from ordinary activities before tax was INR 37.440 million compared with INR 16.552 million for the same period a year ago. Net profit was INR 19.339 million or INR 3.77 per basic and diluted share before and after extraordinary items compared with INR 10.318 million or INR 2.06 per basic and diluted share before and after extraordinary items for the same period a year ago. For the full year, on standalone basis, the company reported net sales of INR 953.219 million compared with INR 758.721 million for the same period a year ago. Profit from operation before other income, finance cost and exceptional items was INR 61.692 million compared with INR 37.204 million for the same period a year ago. Profit from ordinary activities before tax was INR 58.089 million compared with INR 30.788 million for the same period a year ago. Net profit was INR 34.390 million or INR 6.70 per basic and diluted share before and after extraordinary items compared with INR 18.851 million or INR 4.14 per basic and diluted share before and after extraordinary items for the same period a year ago. For the second half, on consolidated basis, the company reported net sales of INR 525.650 million compared with INR 380.208 million for the same period a year ago. Profit from operation before other income, finance cost and exceptional items was INR 43.215 million compared with INR 17.759 million for the same period a year ago. Profit from ordinary activities before tax was INR 38.673 million compared with INR 12.442 million for the same period a year ago. Net profit was INR 20.572 million or INR 3.90 per basic and diluted share before and after extraordinary items compared with INR 6.555 million or INR 1.60 per basic and diluted share before and after extraordinary items for the same period a year ago. For the full year, on consolidated basis, the company reported net sales of INR 983.152 million compared with INR 741.749 million for the same period a year ago. Profit from operation before other income, finance cost and exceptional items was INR 63.167 million compared with INR 33.037 million for the same period a year ago. Profit from ordinary activities before tax was INR 56.487 million compared with INR 24.757 million for the same period a year ago. Net profit was INR 32.789 million or INR 6.52 per basic and diluted share before and after extraordinary items compared with INR 12.819 million or INR 3.41 per basic and diluted share before and after extraordinary items for the same period a year ago.